Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shuang Bing Xu"'
Autor:
Wei-Jing Gong, Peng Cao, Qi-Lin Zhang, Xiao-Yu Han, Shuo-Wen Wang, Yi-Fei Huang, San-Lan Wu, Qiang Li, Rui Zhang, Shuang-Bing Xu, Ya-Ni Liu, Shao-Jun Shi, Yu Zhang
Publikováno v:
Translational Oncology, Vol 19, Iss , Pp 101393- (2022)
Background: Pemetrexed plus platinum doublet chemotherapy regimen remains to be the standard first-line treatment for lung adenocarcinoma patients. However, few biomarkers can be used to identify potential beneficiaries with maximal efficacy and mini
Externí odkaz:
https://doaj.org/article/2c90231e95a443fe948f6572fb172f11
Autor:
Wei-Jing Gong, Peng Cao, Qi-Lin Zhang, Xiao-Yu Han, Shuo-Wen Wang, Yi-Fei Huang, San-Lan Wu, Qiang Li, Rui Zhang, Shuang-Bing Xu, Ya-Ni Liu, Shao-Jun Shi, Yu Zhang
Publikováno v:
Translational oncology. 19
Pemetrexed plus platinum doublet chemotherapy regimen remains to be the standard first-line treatment for lung adenocarcinoma patients. However, few biomarkers can be used to identify potential beneficiaries with maximal efficacy and minimal toxicity
Autor:
Jun Ye Wang, Ling Juan Chen, Hao Long, Qi Wen Li, Wan Ming Hu, Nai Bin Chen, Li Zhang, Zhong Xing Liao, José López, Song Ran Liu, Qing Song Pang, Shuang Bing Xu, Steven H. Lin, Jing Ping Yun, Min Zhang Guo, Xin Wang, Hui Liu, Bo Qiu, Dong Sheng Yue, Wenhua Liang, Jin Yu Guo, Si Yu Wang, Tian Zhang, Yi Zhao
Publikováno v:
Journal of Cancer
Background: This study aimed to develop a predictive model based on the risk of locoregional recurrence (LRR) in epidermal growth factor receptor (EGFR)-mutant stage III-pN2 lung adenocarcinoma after complete resection. Methods: A total of 11,020 pat
Autor:
Shuang Bing Xu, Xian Zi Yang, Wen Jie Zhang, Qin Yuan, Pin Dong Li, Ben Hui Li, Xiao Hong Liu, Fu Xiang Zhou
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 135:131-140
To investigate potential differences in the expression of Stat6 regulatory genes that may influence IL-4/Stat6 activities (phenotypes) in colon cancer cells.RT-PCR method was employed to examine the constitutive mRNA expression of Stat6 negative regu
Autor:
Yan Zhang, Xiao Hong Liu, Kathryn K. Masker, Jia Yuan, Xian Zi Yang, Pin Dong Li, Ben Hui Li, Walter A. Koltun, Qin Yuan, Michael J. Chorney, Glenn S. Gerhard, Wen Jie Zhang, Shuang Bing Xu, Cheng Dong
Publikováno v:
Cytokine. 42:39-47
IL-4-induced Stat6 signaling is active in a variety of cell types, including immune cells and cancer cells, and plays an important role in the regulation of gene expression. Using EMSA gel shift assay and an antibody to Stat6, we phenotyped two breas
Autor:
Jia Yuan, Qin Yuan, Wen Jie Zhang, Ben Hui Li, Shuang Bing Xu, Pin Dong Li, Feng Li, Xiao Hong Liu, Yan Zhang
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 29(12)
Interleukin-4 (IL-4)-induced Stat6 activities (phenotypes) vary among human cancer cells, of which the HT-29 cell line carries an active Stat6(high) phenotype, while Caco-2 carries a defective Stat6(null) phenotype, respectively. Cancer cells with St
Autor:
Xiao Hong Liu, Shuang Bing Xu, Feng Li, Ben Hui Li, Jia Yuan, Xian Zi Yang, Pin Dong Li, Qin Yuan, Wen Jie Zhang, Yan Zhang
Publikováno v:
Journal of cancer research and clinical oncology. 135(12)
Stat6 signaling is active in cancer cells and IL-4-induced Stat6 activities or Stat6 activational phenotypes vary among cancer cells. This study aimed at investigating possible mechanism(s) involved in the formation of varying Stat6 activities/phenot
Autor:
Xiao Hong Liu, Shuang Bing Xu, Jia Yuan, Ben Hui Li, Yan Zhang, Qin Yuan, Pin Dong Li, Feng Li, Wen Jie Zhang
Publikováno v:
Journal of Interferon & Cytokine Research; Dec2009, Vol. 29 Issue 12, p809-816, 8p